Fondaparinux Sodium recalls
Fondaparinux Sodium products have been recalled 1 time, most recently on 2 Nov 2022. The recalling company is usually AuroMedics Pharma. The most common reason is potency & assay.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Nov 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why fondaparinux sodium is recalled
Companies
Product types
By year
All fondaparinux sodium recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fondaparinux Sodium Injection, USP, 7.5 mg per, Single Dose recalledFondaparinux Sodium | AuroMedics Pharma | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.